Literature DB >> 23612076

Primary pathogenicity analysis of a Chinese Entamoeba histolytica isolate.

Muxia Luo1, Meng Feng, Xiangyang Min, Xueping Li, Junlong Cai, Hiroshi Tachibana, Xunjia Cheng.   

Abstract

This study is the first to isolate an Entamoeba histolytica strain from Chinese amoebic patients and to conduct a detailed examination of its virulence. A fecal sample that contains cysts of E. histolytica was obtained from Guangxi province. The sample was cultured axenically and then cloned by limiting dilution, and named as XLAC. In vitro and in vivo tests were conducted to evaluate the virulence of the Entamoeba isolate. The E. histolytica strain XLAC was successfully cloned and cultured axenically. DNA regions that contain hexokinase, glucose-6-phosphate isomerase, phosphoglucomutase, and heavy subunit of lectin genes were amplified by PCR. The PCR products were then sequenced. Virulence analysis suggested that the XLAC strain was similar to the HM1:IMSS strain at the genetic level. In vitro and in vivo tests also implicated these strains to be similar. These findings may be attributed to the low expression levels of pathogenic genes obtained through realtime PCR. The XLAC strain restored its virulence after it was injected into hamster liver. This study may be a good model for studying virulence changes in E. histolytica.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23612076

Source DB:  PubMed          Journal:  Biosci Trends        ISSN: 1881-7815            Impact factor:   2.400


  2 in total

1.  Amebic lung abscess with coexisting lung adenocarcinoma: a unusual case of amebiasis.

Authors:  Hailong Zhu; Xiangyang Min; Shuai Li; Meng Feng; Guofeng Zhang; Xianghua Yi
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

2.  EhVps23, an ESCRT-I Member, Is a Key Factor in Secretion, Motility, Phagocytosis and Tissue Invasion by Entamoeba histolytica.

Authors:  Ausencio Galindo; Rosario Javier-Reyna; Guillermina García-Rivera; Cecilia Bañuelos; Bibiana Chávez-Munguía; Lizbeth Salazar-Villatoro; Esther Orozco
Journal:  Front Cell Infect Microbiol       Date:  2022-03-14       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.